Sung-Wan Kim, MD, PhD

  • 6Articles
  • 22.5KReads
  • 2014–2025Active
  • 35Collaborators
  • 113Citations

About

Sung-Wan Kim, MD, PhD, is affiliated with the Department of Psychiatry at Chonnam National University Medical School in Gwangju, Republic of Korea. Kim has published extensively on topics including major depressive disorder, delirium, neurology, posttraumatic stress disorder, and schizophrenia/schizoaffective disorders. Research contributions include studies on serum biomarkers for depression subtypes, predictive validity of post-injury assessments for PTSD, and the impact of stigma on quality of life after delirium. Kim’s work has appeared in Psychiatrist.com from 2014 through 2025.

Publications

JCP
Differentiating Subtypes of MDD Using Serum Biomarkers
Original Research

Differentiating Subtypes of MDD Using Serum Biomarkers

June 23, 2025

Significant differences in biomarker profiles were observed across MDD subtypes: the melancholic subtype showed higher cortisol levels and lower serotonin levels, and the atypical subtype showed elevated levels of...
, , , et al
JCP
Predictive Validity of Early Post-Injury CAPS-5 Score for Later PTSD Diagnosis
Original Research

Predictive Validity of Early Post-Injury CAPS-5 Score for Later PTSD Diagnosis

August 5, 2024

A CAPS-5 score of ≥15 provided good predictive accuracy for subsequent PTSD development in the general injured population.
, , , et al
JCP
Letter to the Editor

Correction:

April 24, 2019

, , , et al
JCP
Original Research

Mediators Between Childhood Trauma and Suicidal Ideation

April 2, 2019

History of childhood trauma and adult suicidal ideation are common in adults with schizophrenia. This study explored factors that may mediate between such trauma and ideation in patients with...
, , , et al
JCP
Article

Now You Do, Now You Don' t

August 23, 2017

Patients experiencing delirium and the atypical personality displays that go with it often remember their actions after recovering from their delirious state. This unique study looks at patients' lingering...
, , , et al
JCP
Original Research

Escitalopram Treatment for Depressive Disorder Following Acute Coronary Syndrome: A 24-Week Double-Blind, Placebo-Controlled Trial

October 14, 2014

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe